F Cools
Overview
Explore the profile of F Cools including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vento G, Paladini A, Aurilia C, Alkan Ozdemir S, Carnielli V, Cools F, et al.
Trials
. 2024 Jul;
25(1):433.
PMID: 38956676
Background: Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). The goals of different methods of surfactant administration are to reduce the duration of mechanical...
2.
Muyldermans A, Crombe F, Bosmans P, Cools F, Pierard D, Wybo I
J Hosp Infect
. 2021 Feb;
111:148-154.
PMID: 33581246
Background: Serratia marcescens is notorious for its increasing antimicrobial resistance and potential to cause outbreaks in neonatal intensive care units (NICUs). A promising tool in outbreak investigations is whole-genome sequencing...
3.
de Vries T, Hemels M, Cools F, Crijns H, Yperzeele L, Vanacker P, et al.
Neth Heart J
. 2021 Jan;
29(3):158-167.
PMID: 33411231
Background: Studies on the use of non-vitamin K antagonist oral anticoagulants in unselected patients with atrial fibrillation (AF) show that clinical characteristics and dosing practices differ per region, but lack...
4.
Cools F, Delputte P, Cos P
FEMS Microbiol Rev
. 2021 Jan;
45(4).
PMID: 33399826
This review provides an overview of the most important novel treatment strategies against Streptococcus pneumoniae infections published over the past 10 years. The pneumococcus causes the majority of community-acquired bacterial...
5.
Yang S, Pieper K, Cools F
Biometrika
. 2020 Nov;
107(1):123-136.
PMID: 33162561
Structural failure time models are causal models for estimating the effect of time-varying treatments on a survival outcome. G-estimation and artificial censoring have been proposed for estimating the model parameters...
6.
Cornette L, Mulder A, Debeer A, Malfilatre G, Rigo V, Cools F, et al.
Eur J Pediatr
. 2020 Sep;
180(3):885-892.
PMID: 32970243
Specific recommendations on surfactant administration in late preterm (LPT) infants with pulmonary disease are lacking. We performed an online-based, nationwide survey amongst all (n = 102) Belgian neonatologists to identify...
7.
Cools F, Torfs E, Vanhoutte B, de Macedo M, Bonofiglio L, Mollerach M, et al.
Pathog Dis
. 2018 Sep;
76(7).
PMID: 30215741
Streptococcus pneumoniae, the most common cause of bacterial pneumonia, has developed a wide range of virulence factors to evade the immune system of which the polysaccharide capsule is the most...
8.
Demeulemeester V, Van Hautem H, Cools F, Lefevere J
J Neonatal Perinatal Med
. 2018 Aug;
11(4):439-441.
PMID: 30149475
Neonatal seizures are frequent in neonatal intensive care and the most common cause is perinatal asphyxia. Among other causes, toxin exposure is rare.We present a boy with an uneventful vaginal...
9.
Bijleveld Y, Mathot R, van der Lee J, Groenendaal F, Dijk P, van Heijst A, et al.
Clin Pharmacol Ther
. 2017 May;
103(3):458-467.
PMID: 28555724
The pharmacokinetics (PK) of amoxicillin in asphyxiated newborns undergoing moderate hypothermia were quantified using prospective data (N = 125). The population PK was described by a 2-compartment model with a...
10.
Gotta V, Cools F, Van Ammel K, Gallacher D, Visser S, Sannajust F, et al.
Br J Pharmacol
. 2015 Jun;
172(17):4364-79.
PMID: 26076100
Background And Purpose: Preclinical cardiovascular safety studies (CVS) have been compared between facilities with respect to their sensitivity to detect drug-induced QTc prolongation (ΔQTc). Little is known about the consistency...